Industry › BioTech
Press Releases
Owkin Launches K Pro: The First Agentic AI Co-Pilot for Biopharma Powered by Biological Reasoning Models
Owkin
Oct 16, 2025 13:00 HKT/SGT
Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14
Everest Medicines Limited
Oct 14, 2025 17:38 HKT/SGT
LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"
Eisai
Oct 14, 2025 16:54 HKT/SGT
云顶新耀艾曲莫德亚洲多中心Ⅲ期临床ENLIGHT UC研究（ES101002）结果荣登柳叶刀子刊 展示在亚洲患者中的突破性疗效与安全性
Everest Medicines Limited
Oct 09, 2025 18:24 HKT/SGT
雲頂新耀艾曲莫德亞洲多中心Ⅲ期臨床ENLIGHT UC研究（ES101002）結果榮登柳葉刀子刊 展示在亞洲患者中的突破性療效與安全性
Everest Medicines Limited
Oct 09, 2025 18:24 HKT/SGT
Everest Medicines Announces Publication of Etrasimod's Asian Multicenter Phase III ENLIGHT UC study (ES101002) Results in The Lancet Gastroenterology & Hepatology
Everest Medicines Limited
Oct 09, 2025 18:24 HKT/SGT
"LEQEMBI(R)" (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Approved in China
Eisai
Sep 29, 2025 09:33 HKT/SGT
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
China Medical System Holdings Limited
Sep 28, 2025 16:00 JST
China Medical System (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication
China Medical System Holdings Limited
Sep 28, 2025 15:00 HKT/SGT
康哲藥業（867.HK；8A8.SG）創新藥磷酸蘆可替尼乳膏AD中國三期臨床取得積極結果
China Medical System Holdings Limited
Sep 28, 2025 11:33 HKT/SGT